Organogenesis Holdings Inc. ORGO Operating lease right-of-use asset amortization
Operating lease right-of-use asset amortization at other companies
Other financials
Where this comes from
Reported directly by Organogenesis Holdings Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense.
The official record: Organogenesis Holdings Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organogenesis Holdings Inc.'s operating lease right-of-use asset amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Organogenesis Holdings Inc.'s operating lease right-of-use asset amortization?
- Organogenesis Holdings Inc. (ORGO) reported operating lease right-of-use asset amortization of $2.49M in Q1 2026.
- How has Organogenesis Holdings Inc.'s operating lease right-of-use asset amortization changed year-over-year?
- Organogenesis Holdings Inc.'s operating lease right-of-use asset amortization increased by 24.6% year-over-year, from $2M to $2.49M.
- What is the long-term trend for Organogenesis Holdings Inc.'s operating lease right-of-use asset amortization?
- Over 4 years (2021 to 2025), Organogenesis Holdings Inc.'s operating lease right-of-use asset amortization has grown at a 8.8% compound annual growth rate (CAGR), from $5.95M to $8.34M.